NEW YORK (GenomeWeb News) - Third Wave Technologies said today that it has secured a five-year, $25 million line of credit with healthcare investment company Deerfield Management.
 
Third Wave said it may use the extra capital to market its human papillomavirus tests.
 
The company said any funds it borrows under the facility will have a 7.75 percent interest rate, and an annual two percent non-usage fee will be assessed on the amount the company does not draw.
 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

In Science this week: International Wheat Genome Sequencing Consortium publishes the bread wheat cultivar Chinese Spring reference genome, and more.

At his FDA Law Blog, Jeffrey Gibbs discusses FDA's technical assistance for the draft Diagnostic Accuracy and Innovation Act.

The New York Times reports that genetic testing has uncovered unfaithful penguins at a Utah aquarium.

Cancer researcher loses funding under new Wellcome Trust anti-bullying policies, the Guardian reports.